What is a typical genetic testing workflow for a patient with suspected hereditary cancer syndrome?

Prepare for the Clinical Genetics Test. Utilize flashcards and multiple-choice questions, each with hints and explanations. Achieve success on your exam!

Multiple Choice

What is a typical genetic testing workflow for a patient with suspected hereditary cancer syndrome?

The main idea here is that testing for a suspected hereditary cancer syndrome is a stepwise, informed process that starts before any test is done and continues through results and family implications. First, pre-test counseling is essential to explain why testing is being done, what kinds of results might occur, how results could affect medical management for the patient and relatives, and any psychosocial or insurance implications. Then you choose the appropriate test based on the family history and cancer types—often a gene panel if multiple genes could be involved, or targeted testing if a single gene is strongly suspected. After testing, interpreting the variants carefully is crucial, classifying findings as pathogenic, likely pathogenic, benign, or variants of uncertain significance, and confirming or reclassifying as needed over time. Following that, cascade testing of at-risk relatives helps identify who else may be affected or at risk and can lead to early surveillance or preventive measures. Finally, management uses the test results to tailor care—enhanced surveillance, risk-reducing strategies, and, when relevant, targeted therapies or reproductive planning. Why the other approaches don’t fit: skipping counseling or doing random testing ignores informed consent, risk communication, and the ability to tailor the test to the person’s history; no follow-up neglects essential cascade testing and ongoing interpretation; waiting to test only after therapy misses opportunities for prevention and informed treatment decisions.

The main idea here is that testing for a suspected hereditary cancer syndrome is a stepwise, informed process that starts before any test is done and continues through results and family implications. First, pre-test counseling is essential to explain why testing is being done, what kinds of results might occur, how results could affect medical management for the patient and relatives, and any psychosocial or insurance implications. Then you choose the appropriate test based on the family history and cancer types—often a gene panel if multiple genes could be involved, or targeted testing if a single gene is strongly suspected. After testing, interpreting the variants carefully is crucial, classifying findings as pathogenic, likely pathogenic, benign, or variants of uncertain significance, and confirming or reclassifying as needed over time. Following that, cascade testing of at-risk relatives helps identify who else may be affected or at risk and can lead to early surveillance or preventive measures. Finally, management uses the test results to tailor care—enhanced surveillance, risk-reducing strategies, and, when relevant, targeted therapies or reproductive planning.

Why the other approaches don’t fit: skipping counseling or doing random testing ignores informed consent, risk communication, and the ability to tailor the test to the person’s history; no follow-up neglects essential cascade testing and ongoing interpretation; waiting to test only after therapy misses opportunities for prevention and informed treatment decisions.

More practice questions